RE:Great NewsEoganacht wrote: 8 of the 12 will receive a second treatment. If all of them turned out to be CR at one year we would have our 67%. We should do even better than that as the dosing problem has been rectified for the second treatments and for all new patients. Accelerated approval is looking ever more likely.
Yep, and we'll do way better IMO % wise on that second cohort of 12-13 patients. Getting TLT to that magik number of 25 for FDA AA. :-)